Hári-Kovács András, Soós Judit, Gyetvai Tamás, Facskó Andrea, Végh Mihály
Szemészeti Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Korányi fasor 10-11., 6720.
Szemészeti Klinikai Ismeretek Tanszék, Semmelweis Egyetem, Egészségtudományi Kar Budapest.
Orv Hetil. 2017 Dec;158(50):1998-2002. doi: 10.1556/650.2017.30944.
Sulpha drugs are widely employed in medicine for various diseases and disorders. During the last several decades, numerous papers had been published on supra ciliary and posterior choroidal effusion likely presenting as an idiosyncratic effect of these drugs especially of acetazolamide. In each publication, the effusion was associated with either an acute angle-closure glaucoma or transitory myopia or both of these as leading symptoms. In the current publication, authors report on two cases where the acetazolamide-induced choroidal effusion was an accidental finding without either a myopic shift in refraction or an acute elevation in intraocular pressure. To our best knowledge, ours is the first report in the literature describing this unusual, "silent" form of a sulpha drug-induced choroidal effusion. Since the choroidal involvement may vary in size and location, and is not necessarily associated with acute glaucoma and myopia, one can assume that a considerable amount of acetazolamide-related ocular side-effects will not be discovered. The above case report aims to draw the attention of other specialities to the need for ophthalmic examination for their patients taking sulpha drugs with acute visual deterioration. Orv Hetil. 2017; 158(50): 1998-2002.
磺胺类药物在医学上被广泛用于治疗各种疾病和病症。在过去几十年中,已经发表了许多关于睫状体上腔和脉络膜后积液的论文,这些积液可能是这些药物尤其是乙酰唑胺的特异反应。在每篇出版物中,积液都与急性闭角型青光眼或短暂性近视或这两种症状同时出现有关。在当前的出版物中,作者报告了两例乙酰唑胺引起的脉络膜积液病例,这些积液是偶然发现的,既没有屈光不正的近视性移位,也没有眼压急性升高。据我们所知,我们的报告是文献中第一篇描述这种不寻常的、“无声”形式的磺胺类药物引起的脉络膜积液的报告。由于脉络膜受累的大小和位置可能不同,而且不一定与急性青光眼和近视有关,因此可以推测,大量与乙酰唑胺相关的眼部副作用可能未被发现。上述病例报告旨在引起其他专科医生对服用磺胺类药物且视力急性恶化的患者进行眼科检查必要性的关注。《匈牙利医学周报》。2017年;158(50):1998 - 2002。